Objective: Claudication is the most common manifestation of peripheral arterial disease 4 (PAD) producing significant ambulatory compromise. The purpose of this study was to use 5 advanced biomechanical analysis to characterize the kinematic ambulatory pattern of claudicating 6 patients. We hypothesized that compared to control subjects, claudicating patients have altered 7 kinematic gait patterns that can be fully characterized utilizing advanced biomechanical analysis. were assessed (maximum and minimum flexion and extension angles and ranges of motion) and 15 mean ensemble curves were generated. Time to occurrence of the discrete variables was also 16 identified. 17
INTRODUCTION
to control subjects both before and after the onset of claudication, and that biomechanical kinematic 1 analysis represents a diagnostic tool with appropriate sensitivity to detect subtle differences in a 2 subject's gait. The current kinematic study, which focuses on the lower extremity joints' angular 3 displacement independently of the generating forces, complements the kinetic analysis previously 4 described by our group (18) which evaluated the forces exerted by the subjects weight-bearing limb 5 on the ground. Our work seeks to further enhance our understanding of the abnormal gait in 6 subjects with PAD, thus providing the foundation for the development of new rehabilitation 7 strategies and the quantification of treatment outcomes for patients with symptomatic PAD. 8
METHODS 10
Subjects 11
Institutional Review Board approval was obtained prior to initiation of the study and all 12 subjects provided informed consent. Patients with clinically diagnosed PAD presenting with classic 13 symptomatic claudication were recruited from our vascular surgery clinics. Selected patients were 14 free of any associated co-morbidities limiting or altering their gait. Specifically, subjects were 15 excluded if they had recent myocardial infarction or ambulation-limiting heart failure, angina or 16 pulmonary disease. Additionally, subjects were excluded if they had gait altering neurological or 17 musculoskeletal disease such as paresis, sciatica, arthritis, diabetic neuropathy or arthropathy. 18
History and physical examination of the subjects evaluated was performed by board certified 19 vascular surgeons (JJ, IP). Lower extremity arterial disease was verified by classic clinical 20 symptoms confirmed utilizing noninvasive testing (ankle-brachial indexes < 0.9) and the level of 21 disease identified with the aid of noninvasive vascular examination complemented by computerized 22 tomography, magnetic resonance or invasive angiography. Based on this assessment, limbs with 23 occlusive disease and typical Rose claudication symptoms (19) were established as "claudicating 24 limbs" and selected for biomechanical analysis. 25 1 examination performed by vascular surgeons documented absence of PAD and co-morbidities as 2 described for PAD patients. Absence of PAD was confirmed by noninvasive testing (ankle-brachial 3 indexes) and absence of pain during ambulation. Each leg of these individuals was used as "control 4 limb". To eliminate variability in gait due to shoes, all subjects wore the same standard laboratory 5 shoes (Cross Trekkers, Payless Shoes, Topeka, KS). 6
Lower extremity kinematics 7
Upon arrival in the laboratory, patients were prepared for data collection. Height, weight, 8 body mass index, age and anthropometric measurements were obtained. Reflective markers were 9 placed at specific anatomical locations of each subject's lower limb utilizing the systems used by 10
Vaughan (20) and Nigg (21) and as described in Figure 1 . The subjects' lower extremity three-11 dimensional kinematics was acquired with a high speed analog video Peak Performance system at 12 60Hz (Peak Performance Technologies, Englewood, CO). Marker identification was conducted 13 using the Peak Motus (Vicon-Peak Performance Technologies, Inc.) software. The exported marker 14 data was scaled and smoothed using a Butterworth low-pass filter with a selective cut-off algorithm 15 according to Jackson (22) . The cut-off values used were 7-14 Hz. This analysis was performed using 16 custom software in Matlab (Mathworks Inc. Natick, Mass), where the exported data was also 17 converted to unit vectors for each local reference frame. Anthropometric measurements were 18 combined with three-dimensional marker data from the anatomical position calibration trial (see 19 below) to provide positions of the joint centers and define anatomical axes of joint rotations (20) . The 20 positions of the reflective markers during the movement provided the three-dimensional joint angles 21 and were determined through triangulation of the position of the markers. 22
Prior to the walking trials, patients stood in the calibration device for five seconds while 23 kinematic video was collected with each leg in view of the cameras. The standing calibration trial 24 provided an anatomical reference position. The calculation of three-dimensional lower extremity 25 segment orientations and relevant joint angles was referred to this position. Kinematic data wascollected during the stance phase of walking (from heel contact to toe off). Initially five walking 1 trials were acquired from each PAD subject without pain present and represented the "pain free" 2 condition (PAD-PF). During this condition the patients were required to rest in a chair for at least 3 five minutes before, and between trials to ensure pain free measurements. After PAD patients 4 completed the pain free walking trials, claudication pain was induced. This was accomplished by 5 having patients walk on a treadmill at a 10% grade at 0.67 m/s until claudication was induced 6 (usually patients become symptomatic after 1 to 3 minutes on the treadmill) and then for 7 approximately 45 additional seconds. Patients returned to the walkway immediately where five 8 more walking trials were performed without any resting between the trials. Claudication pain was 9 present throughout these trials and represented the claudication or "pain" condition of the PAD 10 patients (PAD-P). Data from the healthy controls was collected following the protocol used to 11 obtain the pain free data from the PAD patients, with claudication data not obtained due to lack of 12 PAD in these individuals. 13
Data Analysis 14
Joint angles from the hip, knee and ankle were analyzed for the two conditions of the PAD 15 patients and for the controls. Dependent variables calculated were the range of motion, the 16 maximum and the minimum of the joints' flexion and extension angles. All kinematic parameter 17 data files were normalized to 100 points for the stance phase using a cubic spline routine to enable 18 mean ensemble curves to be derived for each condition of each subject. All normalization occurred 19 after maximums and minimums were determined to ensure that the normalization did not distort 20 these values (23, 24) . 21
Statistical analysis 22
Statistical analysis was performed using SPSS (version 15; SPSS Inc, Chicago, Ili). Subject 23 and group means were calculated and inferential statistics were used to compare the different 24 groups. Independent t-tests were used to compare mean values of PAD patients (PAD-PF and PAD-25 observed in claudicants when compared to controls in both PAD-PF and PAD-P conditions (Table  23 1; Figure 2 ). Since no differences were found for maximum (positive values) ankle dorsiflexion 24 (Table 1) , these results are reflected as a deeper "valley" on the ankle mean ensemble curve forflexion and maximal dorsiflexion of the ankle joint during the stance phase was significantly altered 1 when comparing PAD-P to control subjects. The PAD-P patient reached minimum ankle plantar 2 flexion faster and maximum dorsiflexion later than the control subject (Table 2 ). When analyzing 3 the effect of claudication on joint motion at the knee and hip, no significant differences were noted 4 in joint angles. 5
When analyzing the effect of claudication pain by comparing the PAD-PF to PAD-P 6 conditions, there were no significant differences noted in joint motion at each joint level or in the 7 timing of specific points within the gait cycle. These results are also reflected in the mean ensemble 8 curves since the lines for PAD-P and PAD-PF are overlapping throughout stance (Figure 2 secondary to nerve damage and muscle weakness from chronic ischemia (28, 29, 33) . This could result 20 in poor eccentric motor control from the foot dorsiflexors (anterior and lateral compartment leg 21 muscles) in combination with suboptimal plantar flexor function (posterior compartment muscles). 22
Taken together, these findings represent either a compensatory mechanism to maintain stability due 23 to inherent neuromuscular weakness of the lower limb or alternatively an adaptation to altered 24 neuromuscular function due to PAD. Consistent with any dysfunctional gait, PAD patients have a 25 deviation from normal walking parameters that results in an increased work requirement and energy 26 dysfunctional gait prior to the onset of claudication pain despite what appears to be "normal" gait 18 by simple visual analysis. These findings we believe reflect a baseline lower extremity dysfunction 19 in PAD patients with origins at the cellular level (26, 27) . The abnormalities contributing to the 20 baseline gait dysfunction include axonal nerve loss (28, 29) and mitochondrial dysfunction (30) (31) (32) (33) (34) (35) both 21 of which could account for the underlying gait dysfunction found in PAD patients from the first 22 step during ambulation. Ischemia superimposed on underlying neuromuscular dysfunction would 23 then result in variably worsening gait as seen in our previous kinetic analysis (18) . 24 PAD on gait biomechanical parameters, only before the onset of claudication pain (17) . Although 5 difficult to compare to our study due to differing methodologies, this study also found differences at 6 the ankle. In contrast to our results, they found differences in the knee ROM and hip extension. Our 7 methodology only included patients with clinically diagnosed femoro-popliteal disease and focused 8 the analysis of the joints to the stance phase of the gait cycle. Crowther et al did not specify a level 9 of disease among the patients and included the swing phase in the analysis of the joints' ranges of 10 motion. Another factor contributing to the precision of our results is the capability of our lab to 11 provide a three-dimensional analysis given the number of cameras used, Crowther et al, in contrast, 12 utilized a two-dimensional kinematic analysis of the sagittal plane, which is vulnerable to 13 perspective error (37, 38) . Table 1 . Group means of joint angle parameters in controls and PAD patients both before and after the onset of claudication.
PAD-PF, pain free condition PAD patient; PAD-P, pain condition PAD patient; NS statistically non significant; ROM, range of motion † Control vs. PAD-PF ‡ Control vs. PAD-P PAD-PF vs. PAD-P Table 2 : Group means of time to maximal flexion and extension of the joints in controls and PAD patients both before and after the onset of claudication.
PAD-PF, pain free PAD patient; PAD-P, pain condition PAD patient; NS statistically non significant; ROM, range of motion † Control vs. PAD-PF Table Legend 
